TNF and melanoma: Limiting the distribution volume from the whole body to a leg or an arm, as is accomplished in isolated limb perfusion, could significantly improve tumor response and avoidance of amputation in patients with advanced melanoma or sarcoma, when melphalan was administered in combination with TNF-α, compared to treatment with melphalan alone [61,62,63].